Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized open-label active-controlled trial of PA9159 inhalation aerosol in adults with bronchial asthma
CTR20254006Phase 2Active
- Sponsor
- Anhui Bolatu Pharmaceutical Technology
- Start
- Oct 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pa9159 in asthma, sponsored by Anhui Bolatu Pharmaceutical Technology. Started Oct 2025; status: active.
02
Drugs
pa9159
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20254006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254006.